Picture of Ingredion logo

INGR Ingredion News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapContrarian

Ingredion misses Q1 adjusted EPS estimates, cuts FY outlook

Overview

U.S. ingredient solutions provider's Q1 net sales fell 1% yr/yr

Q1 adjusted EPS missed analyst expectations

Company cut full-year adjusted EPS guidance, citing operational challenges at Argo facility

Outlook

Ingredion sees full-year 2026 reported EPS at $9.60-$10.30 and adjusted EPS at $10.45-$11.15

Company expects 2026 net sales to be flat to up low single-digits, with reported operating income down high single-digits

Result Drivers

ARGO FACILITY ISSUES - Operational challenges and a longer-than-expected recovery at the Argo facility weighed on Food & Industrial Ingredients—U.S./CAN results

SOFTER DEMAND - Lower volumes and less favorable mix in Food & Industrial Ingredients—U.S./CAN contributed to the overall sales decline

TEXTURE & HEALTHFUL SOLUTIONS GROWTH - Continued broad-based net sales volume growth in Texture & Healthful Solutions, driven by strong customer demand

Company press release: ID:nGNXt7PJ8

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 Adjusted EPSMiss$2.34$2.47 (6 Analysts)
Q1 EPS$2.22
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell" The average consensus recommendation for the food processing peer group is "buy" Wall Street's median 12-month price target for Ingredion Inc is $126.00, about 17.9% above its May 4 closing price of $106.88 The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 10 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ingredion

See all news